TELO Latest Press Releases

-- April 24, 2026 --

Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn) ACCESS Newswire 9:00 AM

-- March 31, 2026 --

Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) in Advanced and Metastatic Triple-Negative Breast Cancer ACCESS Newswire 8:05 AM

-- February 17, 2026 --

Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models ACCESS Newswire 8:00 AM

-- February 5, 2026 --

Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging ACCESS Newswire 8:00 AM

-- January 5, 2026 --

Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models ACCESS Newswire 8:00 AM

-- December 18, 2025 --

Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development ACCESS Newswire 7:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software